Behandlingen skal fortsætte, indtil risikoen for blodpropper i venerne er aftaget, sædvanligvis mindst fem til ni dage.
In the treatment of DVT or PE, the recommended dose is 7.5 mg once a day by subcutaneous injection, usually for seven days.